Showing 6721-6730 of 7665 results for "".
Protect Your Assets in Case of Divorce: A 2019 Perspective
https://practicaldermatology.com/topics/practice-management/protect-your-assets-in-case-of-divorce-a-2019-perspective/23096/What you need to do now to ensure you’re protected in case your marriage dissolves.To Sell or Not To Sell: Strategic Options and Realizing Value
https://practicaldermatology.com/topics/practice-management/to-sell-or-not-to-sell-strategic-options-and-realizing-value/20418/Is this the right time to make a change? Here's what you need to know.Almirall/Allergan, LEO/Bayer Deals
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-almirall-allergan-leo-bayer-deals/18240/Leo Pharma has agreed to acquire Bayer's global prescription dermatology unit, and Almirall will acquire Allergan's US portfolio of medical dermatology drugs. When it comes to patient engagement, aesthetic practices often have the right mindset, but they may lack the skills or time necessary to execPsoriasis Comorbidities: Assessing Risks and the Role of Dermatologists
https://practicaldermatology.com/topics/psoriasis/psoriasis-comorbidities-assessing-risks-and-the-role-of-dermatologists-/18242/Ronald Prussick, MD discusses the most common comorbidities of psoriasis and the risks patients have for cardiovascular issues, depression, fatty liver disease, vitamin D deficiency, and more. He talks to host Nancy Samolitis, MD about the role dermatologists play in assessing and treating these risValeant's Plan for Derm; VCS Highlights
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-valeant-s-plan-for-derm-vcs-highlights/18587/Amid reports that its Obagi and Solta units may be sold off, Valeant Pharmaceuticals is assuring investors that the company is focused on the future and has plans to fix its dermatology unit. Vegas Cosmetic Surgery has wrapped up its 12th program, gathering dermatologists, plastic surgeons, facial pBiosimilar Recommended; Saunders to Head New Pfizer/Allergan Organization
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-biosimilar-recommended-saunders-to-head-new-pfizer-allergan-organization/18825/An FDA committee has recommended Pfizer's Inflectra, biosimilar to infliximab, developed by Celltrion. Sunbelt Melanoma Trial finds no benefit for IFN in Phase III melanoma. Pfizer/Allergan provides details on structure of new organization and announces leadership, including President and COO BrentJuvederm Approved for Lips, CoolMini Applicator Cleared
https://practicaldermatology.com/topics/psoriasis/juvederm-approved-for-lips-coolmini-applicator-cleared/18828/In this edition, a look at Allergan's Juvederm Voluma XC approval for lips an Zeltiq's CoolMini applicator for treatment of the sub mental area. Plus, there's new data for secukinumab in psoriatic arthritis (PSA) and Kathleen Sebelius has joined the Board of Directors of Dermira.How To Protect Against Losing Assets In A Divorce
https://practicaldermatology.com/topics/practice-management/how-to-protect-against-losing-assets-in-a-divorce/21399/Tips for minimizing potential financial pain from a marital split.Natural Ingredients and Their Applications in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/natural-ingredients-and-their-applications-in-dermatology/22022/Understanding the role of natural ingredients in therapeutic regimens may help physicians to harness these agents for maximum effect.Combination Therapy for Vitiligo Treatment
https://practicaldermatology.com/series/updates-vitiligo/combination-therapy-vitiligo-treatment/26561/Dr. Natasha Atanaskova Mesinkovsa, Vice Chair for Clinical Research at the University of California, Irvine, talks with Practical Dermatology about phototherapy in combination with topical JAK inhibitors for vitiligo. Dr. Mesinkovska also discusses the efficacy of at-home devices and mortality rates